Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:High Purity Tenofovir Disoproxil Fumarate 202138-50-9,Best Offer 202138-50-9,Tenofovir Disoproxil Fumarate TDF CAS NO 202138-50-9
Conbott Pharmtech Co.,Ltd. High Purity Tenofovir Disoproxil Fumarate 202138-50-9,Best Offer 202138-50-9,Tenofovir Disoproxil Fumarate TDF CAS NO 202138-50-9
Home > Products > Inhibitors > Reverse Transcriptase Inhibitor > Tenofovir Disoproxil Fumarate, CAS 202138-50-9
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Tenofovir Disoproxil Fumarate, CAS 202138-50-9

Share to:  
    Payment Type: T/T,L/C
    Delivery Time: 7 Days

Basic Info

Model No.:  202138-50-9

Additional Info

Packaging: 25KGS/DRUM

Productivity: Customized

Brand: CONBOTTPHARM

Transportation: Air

Place of Origin: CHINA

Supply Ability: Commercial

Certificate: DOCUMENT SUPPORT

Product Description

Tenofovir disoproxil fumarate CAS 202138-50-9 is the prodrug of tenofovir (PMPA, 2) ,which is new nucleotide reverse transcriptase Inhibitors and mainly used for HIV clinically. We have deep analysis on the production situation of that hemifumarate and impurities relevant to this drug. We have a relevantly complete iimpurity file system,stable production environment and adequate inventory.

Tenofovir disoproxil fumarate CAS 202138-50-9 listed for the treatment of AIDS in 2001 which was also approved for the treatment of chronic hepatitis B in 2008. It`s featured for its good tolerance, low resistance, withdrawal rebound rate, renal toxicity and so on. Especially it has a relatively good clinic application prospect for patients with HIV and HBV infection. It has water solubility, and can be rapidly absorbed and degraded into tenofovir which is adenosine monophosphate acyclic nucleoside analogues which will phosphorylated to tenofovir bisphosphonates under the function of cell kinases It inhibits the virus in the following two ways: one is to competitively combine with natural deoxyribose substrates to inhibit viral polymerase; the other way is to insert into virus DNA and cause DNA chain elongation termination, thus play achieving the effect of curing AIDS and hepatitis B.


  • Thera. Category:Anti-hepatitis
  • Cas No.:202138-50-9
  • Synonym: Tenofovir disoproxil fumarate;TENOFOVIR DISOPROXIC;9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate
  • Molecular Formula: C19H30N5O10P
202138-50-9


  • Molecular Weight:635.51
  • Pharmacopeia: In house Spec.
  • Specifications:Available on request
  • Packing:Export worthy packing
  • Material Safety Data Sheet:Available on request
  • Specifications of TDF


Looking for ideal High Purity Tenofovir Disoproxil Fumarate 202138-50-9 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Best Offer 202138-50-9 are quality guaranteed. We are China Origin Factory of Tenofovir Disoproxil Fumarate TDF CAS NO 202138-50-9. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > Reverse Transcriptase Inhibitor

Product Images
  • Tenofovir Disoproxil Fumarate, CAS 202138-50-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?